• Nintedanib (BIBF 1120): A Translational Test

  2026-08-13

  Nintedanib (BIBF 1120) offers a strategically useful way to interrogate VEGFR, FGFR, and PDGFR signaling across oncology and fibrosis models. This article connects its triple angiokinase mechanism with ATRX-defined glioma vulnerability, experimental design, biomarker strategy, and translational decision-making.

• Fenipentol: Applied Workflows and Troubleshooting

  2026-08-13

  Fenipentol, also called 1-Phenyl-1-pentanol, supports exploratory studies spanning hepatobiliary secretion, estrogen receptor biology, and assay-guided liver research. This practical guide emphasizes reproducible stock preparation, secretion workflows, isomer-aware interpretation, and troubleshooting rather than treating docking or historical pharmacology as clinical proof.

• GLI2, WNT, and Prostaglandins in Immune Evasion

  2026-08-12

  DeVito et al. identify GLI2 as a mechanistic hub linking mesenchymal transformation to tumor immune evasion and resistance to anti-PD-1 therapy. The study shows that GLI2 coordinates WNT ligand production and prostaglandin signaling, reshaping myeloid and lymphoid immune compartments and providing a rationale for pathway-directed combination studies.

• Thiothixene: From PK Evidence to Efferocytosis

  2026-08-11

  Thiothixene is a typical antipsychotic agent with an unusually informative research profile spanning dopamine receptor pharmacology, macrophage efferocytosis, and drug-interaction analysis. This article explains how pharmacokinetic evidence can sharpen interpretation of Thiothixene-based neuroimmune assays without conflating clinical exposure with in vitro activity.

• SCUBE3 Antibody Therapy Rewires Cancer Signaling

  2026-08-11

  The reference study identifies secreted SCUBE3 as a multifunctional cancer dependency that links oncogenic receptor signaling, DNA damage repair, therapy resistance, and immune suppression. Its neutralizing antibody approach produced antitumor activity in preclinical models by disrupting SCUBE3-associated FOXR2 and c-Myc signaling while restoring immune-related gene expression.

• Rimonabant (SR141716) in Mechanistic Pain Assays

  2026-08-10

  Rimonabant (SR141716) gives researchers a selective CB1 blockade tool for separating cannabinoid-dependent behavior from adenosine A2A-mediated effects in terpene and neuropathic-pain studies. Its high CB1 selectivity also supports appetite regulation research, obesity research, inflammatory assays, and controlled endocannabinoid-system experiments.

• Phenacetin in Human Intestinal Organoid PK

  2026-08-09

  Phenacetin can serve as a chemically defined benchmark for translational pharmacokinetic studies when evaluated in human pluripotent stem cell-derived intestinal organoids. This article connects the compound’s absorption and metabolism questions with recent organoid advances, while emphasizing vehicle control, analytical endpoints, nephropathy-related safety boundaries, and research-only use.

• Doxorubicin: From DNA Damage to Cardiotoxicity

  2026-08-08

  Doxorubicin, also known as Adriamycin, is a powerful DNA-directed cancer chemotherapy drug and a valuable mechanistic probe. This article connects its tumor-cell activity with cardiotoxicity research and shows how assay design, timing, and orthogonal readouts improve interpretation.

• 6-Thioguanine Chitosan Nanoparticles in Cancer Models

  2026-08-07

  This study investigated chitosan nanoparticles as a delivery system for 6-thioguanine, with or without curcumin, to address the drug’s limited bioavailability and short half-life. The formulation produced sustained release and stronger in vitro responses than free 6-thioguanine in selected breast and ovarian cancer models, while also providing evidence of apoptosis, G2/M arrest, and DNA demethylating activity.

• Precision Caspase-3/7 Inhibition: Translational Impact for A

  2026-08-07

  Explore the mechanistic depth and translational strategies enabled by selective, reversible caspase-3/7 inhibition. This article integrates recent host-pathogen research, advanced workflow insights, and practical guidance for leveraging Caspase-3/7 Inhibitor I in apoptosis modulation—from mechanistic cell death dissection to disease model innovation.

• GSH and GSSG Assay Kit: Redefining Reduced Glutathione Detec

  2026-08-06

  The GSH and GSSG Assay Kit delivers unmatched sensitivity and workflow flexibility for quantifying redox state dynamics in diverse biological samples. Its robust protocol, validated in advanced immunometabolism and tumor microenvironment research, empowers researchers to unravel oxidative stress mechanisms with confidence.

• Nintedanib (BIBF 1120) Precision: Tumor Angiogenesis and ATR

  2026-08-06

  Explore how Nintedanib (BIBF 1120) targets angiogenesis and reveals new vulnerabilities in ATRX-deficient cancer cells. This article delivers deep mechanistic insights and practical guidance for antiangiogenic research, setting it apart from prior content.

• Phosphotungstic Acid Negative Stain Solution: Advanced EM Wo

  2026-08-05

  Unlock precision virus and glycan visualization with 2% Phosphotungstic Acid Negative Stain Solution from APExBIO. This guide delivers step-by-step EM protocols, real-world troubleshooting, and cross-domain insights for antiviral research.

• AMD-070 Hydrochloride: Empowering CXCR4 Antagonist Workflows

  2026-08-05

  Mavorixafor hydrochloride (AMD-070 hydrochloride) sets a new standard for targeting the CXCR4/CXCL12 axis, enabling robust, reproducible results in immunology and anti-HIV research. With exceptional solubility and selectivity, it transforms experimental reliability and clinical translation, especially in rare immunodeficiencies like WHIM syndrome.

• p-Cresyl Sulfate Drives Aortic Valve Calcification via Kloth

  2026-08-04

  This study defines how p-Cresyl sulfate (PCS), a uremic toxin, accelerates calcification of aortic valvular interstitial cells (VICs) through modulation of klotho and sirtuin-1 (SIRT1) signaling. The findings reveal mechanistic links between PCS accumulation in chronic kidney disease and increased cardiovascular risk, highlighting actionable targets for future interventions.

8406 records 2/561 page Previous Next 12345 下5页 Last page